Kura Oncology, Inc. (NASDAQ:KURA) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to Kura Oncology's Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Kura Oncology Inc. (KURA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | EcoR1 Capital Oleg Nodelman | 6,638,371 | $82,382,184 | 2.5% | |
| 2. | Suvretta Capital Management Aaron Cowen | 6,376,815 | $79,136,274 | +57% | 3.32% |
| 3. | Biotechnology Value Fund / BVF Inc Mark Lampert | 3,800,983 | $47,170,199 | +19% | 1.99% |
| 4. | VenBio Select Advisor Kurt Von Emster | 3,105,000 | $38,533,050 | -12% | 0.57% |
| 5. | Holocene Advisors Brandon Haley | 2,538,605 | $31,504,088 | -27% | 0.19% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.16 | 83,540 | Large Shareholder | 4,408,097 | 2018-12-21 | Filing | |
| $13.84 | 51,879 | Large Shareholder | 4,324,557 | 2018-12-19 | Filing | |
| $13.82 | 78,469 | Large Shareholder | 4,272,678 | 2018-12-18 | Filing | |
| $13.89 | 25,217 | Large Shareholder | 4,220,729 | 2018-12-13 | Filing | |
| $13.91 | 15,321 | Large Shareholder | 4,195,512 | 2018-12-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.89 | 1,821 | Officer | 21,214 | 2023-01-27 | Filing | |
| $13.89 | 1,906 | Officer | 20,605 | 2023-01-27 | Filing | |
| $13.89 | 866 | Officer | 16,841 | 2023-01-27 | Filing | |
| $13.89 | 682 | Officer | 17,707 | 2023-01-27 | Filing | |
| $13.87 | 4,840 | Officer | 27,675 | 2023-01-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 5,162,836 | $64,070,795 | 0% | |
| 2. | 4,446,427 | $55,180,159 | 0% | |
| 3. | 3,405,169 | $42,258,148 | 0% | |
| 4. | 1,849,947 | $22,957,842 | 9.8% | |
| 5. | 1,519,327 | $18,854,849 | 0.02% |
News See All
10 Small-Cap Growth Stocks Hedge Funds Love
It’s been a rough year for growth stocks to say the least.
Did The Smart Money Play Kura Oncology, Inc. (KURA) Correctly?
Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.
Here is What Hedge Funds Think About Kura Oncology, Inc. (KURA)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
10 Pharmaceutical Stocks to Buy According to Brandon Haley's Holocene Advisors
In this article, we take a look at the 10 pharmaceutical stocks to buy according to Brandon Haley’s Holocene Advisors.
Is Kura Oncology, Inc. (KURA) A Good Stock To Buy?
A whopping number of 13F filings filed with U.S.
Is KURA Stock A Buy or Sell?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Is KURA A Good Stock To Buy According To Hedge Funds?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 817 active prominent money managers and analyze their...
Hedge Funds Never Been This Bullish On Kura Oncology, Inc. (KURA)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Did Hedge Funds Make The Right Call On Kura Oncology, Inc. (KURA) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Billionaire Hedge Funds
